BMY vs FLY · P/E 17, rev $48.19B vs rev $30.8M
Bristol-Myers Squibb Company (BMY) versus Firefly Aerospace Inc. Common Stock (FLY) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Firefly Aerospace Inc. Common Stock (FLY) is a aerospace & defense company listed on NASDAQ.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported FLY revenue for 2025-09-30 was $30.8M. Net income was -$257.3M. Revenue was up 97.9% from 2025-06-30 to 2025-09-30. FLY currently screens at market cap $4.84B.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. FLY currently screens at market cap $4.84B.
Not investment advice. Open the BMY and FLY stock pages for the full models.
Not investment advice.